Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index E

Eardrum: Sec. 3, Ch. 37; Sec. 3, Ch. 37
Ears: Sec. 3, Ch. 37 (see also Hearing, loss of)
aging of: Sec. 1, Ch. 2
disorders of
     dizziness and: Sec. 3, Ch. 20; Sec. 3, Ch. 20
irrigation of: Sec. 3, Ch. 37
ringing in (tinnitus): Sec. 3, Ch. 37
Earwax: Sec. 3, Ch. 37; Sec. 1, Ch. 2; Sec. 3, Ch. 37
dizziness and: Sec. 3, Ch. 20
Ear canal, bony
projections in: Sec. 3, Ch. 37
Eating: (see also Diet; Food; Nutrition)
hospitalization and: Sec. 2, Ch. 11
low blood pressure after: Sec. 3, Ch. 20; Sec. 3, Ch. 20
in nursing home: Sec. 3 Ch. 17 [sidebar]
in nursing homes: Sec. 2 Ch. 14 [sidebar]
occupational therapy for: Sec. 2, Ch. 13
tooth loss and: Sec. 3, Ch. 39
Eating disorders
information resources on: 886
ECG: (see Electrocardiography)
Echinacea: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Echocardiography: Sec. 2, Ch. 10
in aortic aneurysm: Sec. 3, Ch. 44
in aortic dissection: Sec. 3, Ch. 44
in atrial flutter and fibrillation: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in fainting evaluation: Sec. 3, Ch. 20
in heart failure: Sec. 3, Ch. 46
in heart valve disorders: Sec. 3, Ch. 48
in stroke evaluation: Sec. 3, Ch. 28
Ectropion: Sec. 3, Ch. 36
Eczema craquelé: Sec. 3, Ch. 35
Edema: (see Swelling [edema])
Education
continuing: Sec. 4, Ch. 61, 884
driver: Sec. 4, Ch. 62
EEG: (see Electroencephalography)
Effusion
around heart (pericardial): Sec. 3, Ch. 44
EGD: (see Esophagogastroduodenoscopy)
Elastic stockings
in chronic venous insufficiency: Sec. 3, Ch. 44
in varicose veins: Sec. 3, Ch. 44
Elder mistreatment: Sec. 4, Ch. 64
Eldercare Locator: Sec. 4, Ch. 64
Electrical stimulation
of muscles: Sec. 2, Ch. 13
Electrocardiography (ECG): Sec. 2, Ch. 10
in abnormal heart rhythms: Sec. 3, Ch. 47; Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in dizziness evaluation: Sec. 3, Ch. 20
in fainting evaluation: Sec. 3, Ch. 20
in fall evaluation: Sec. 3, Ch. 21
in hyperkalemia: Sec. 3, Ch. 18
in stroke: Sec. 3, Ch. 28
in ventricular tachycardia: Sec. 3, Ch. 47
Electrocautery
in rosacea: Sec. 3, Ch. 35
Electroconvulsive (shock) therapy: Sec. 3, Ch. 32
Electroencephalography (EEG): Sec. 2, Ch. 10
in fainting evaluation: Sec. 3, Ch. 20
Electrolytes: Sec. 3, Ch. 18
abnormal levels of: Sec. 3, Ch. 18
after surgery: Sec. 2, Ch. 12
Electromyography (EMG): Sec. 2, Ch. 10; Sec. 3, Ch. 29; Sec. 3, Ch. 42
Electrophoresis
in multiple myeloma: Sec. 3, Ch. 51
Electrophysiologic testing
in abnormal heart rhythms: Sec. 3, Ch. 47; Sec. 3, Ch. 47
Embolism
in abnormal heart rhythms: Sec. 3, Ch. 47
in aneurysm: Sec. 3, Ch. 44
in atherosclerosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44
in deep vein thrombosis: Sec. 3, Ch. 44
in peripheral arterial disease: Sec. 3, Ch. 44
pulmonary
     bed rest-related: Sec. 3, Ch. 23
     in deep vein thrombosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44
     prevention of: Sec. 3, Ch. 44; Sec. 3, Ch. 44
     after stroke: Sec. 3, Ch. 28
retinal: Sec. 3, Ch. 36
Emergency department: Sec. 2, Ch. 11
for abnormal heart rhythms: Sec. 3, Ch. 47
for heart attack: Sec. 3, Ch. 45
for heart failure: Sec. 3, Ch. 46
Emphysema: Sec. 3, Ch. 53
heart failure and: Sec. 3 Ch. 46 [detail]
Empty-calorie foods: Sec. 2, Ch. 5
Enalapril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Encephalitis
in influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52
End-of-life care: Sec. 2, Ch. 16; Sec. 2, Ch. 16
advance directives and: Sec. 2, Ch. 16
assisted suicide and: Sec. 2, Ch. 16
bedside atmosphere during: Sec. 2, Ch. 16
in cancer: Sec. 3, Ch. 50
in COPD: Sec. 3, Ch. 53
in dementia: Sec. 3, Ch. 27
depression and: Sec. 2, Ch. 16
in hart failure: Sec. 3, Ch. 46
hospice care for: Sec. 2, Ch. 9; Sec. 2, Ch. 16
loss of appetite and: Sec. 2, Ch. 16
pain during: Sec. 2, Ch. 16
in Parkinson's disease: Sec. 3, Ch. 30
in progressive supranuclear palsy: Sec. 3, Ch. 30
Endarterectomy: Sec. 3, Ch. 28; Sec. 3, Ch. 36
Endocrine system
aging of: Sec. 1, Ch. 2
Endocrinologist: Sec. 2, Ch. 9
Endometrium
biopsy of: Sec. 3, Ch. 58
Endorphins: Sec. 3, Ch. 32
Endoscopy: Sec. 2, Ch. 10
of digestive system: Sec. 2, Ch. 10; Sec. 2, Ch. 10
in gastroesophageal reflux: Sec. 3, Ch. 54
of joint: Sec. 2, Ch. 10
in swallowing difficulty: Sec. 3, Ch. 54; Sec. 3, Ch. 54
Endovascular repair: Sec. 3, Ch. 44
Enema
tap water: Sec. 3, Ch. 55
Enoxaparin: Sec. 3, Ch. 45
Entacapone: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Enterocele: Sec. 3, Ch. 58; Sec. 3, Ch. 58
Entropion: Sec. 3, Ch. 36
Enzymes
supplemental: Sec. 2, Ch. 7
Epidermis: Sec. 3 Ch. 35 [detail]; Sec. 3, Ch. 35
Eplerenone: Sec. 3, Ch. 46; Sec. 3, Ch. 46
Epley maneuver: Sec. 3, Ch. 20; Sec. 3, Ch. 20
Eprosartan
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Eptifibatide: Sec. 3, Ch. 45
Erectile dysfunction: Sec. 3, Ch. 59
information resources on: 886
Erythrocyte sedimentation rate: Sec. 3, Ch. 41; Sec. 3, Ch. 42
Erythrocytes: (see Red blood cells)
Erythropoietin: Sec. 3, Ch. 49
in anemia of chronic disease: Sec. 3, Ch. 49
in bone marrow disorders: Sec. 3 Ch. 49 [sidebar]
in chronic lymphocytic leukemia: Sec. 3, Ch. 51
in multiple myeloma: Sec. 3, Ch. 51
in myelofibrosis: Sec. 3, Ch. 49
in polycythemia: Sec. 3, Ch. 49
Escherichia coli infection: Sec. 3, Ch. 52
Escitalopram: Sec. 3, Ch. 32
Esophagitis: Sec. 3, Ch. 54
Esophagogastroduodenoscopy: Sec. 2, Ch. 10; Sec. 2, Ch. 10
in anemia: Sec. 3, Ch. 49
Esophagus
balloon dilation of: Sec. 3, Ch. 54
Barrett's: Sec. 3, Ch. 54
bleeding from: Sec. 3, Ch. 54
cancer of: Sec. 3, Ch. 54; Sec. 3, Ch. 54
diverticulum of: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
drug-related damage to: Sec. 3, Ch. 54
inflammation of (esophagitis): Sec. 3, Ch. 54
pH of: Sec. 3, Ch. 54
Schatzki's ring of: Sec. 3, Ch. 54
spasms of: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
sphincters of: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
     botulinum toxin injection of: Sec. 3, Ch. 54
     cutting of: Sec. 3, Ch. 54
     in gastroesophageal reflux: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
stricture of: Sec. 3, Ch. 54; Sec. 3, Ch. 54
ulcers of: Sec. 3, Ch. 54
varicose veins of
     in myelofibrosis: Sec. 3, Ch. 49
webs of: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
ESR (erythrocyte sedimentation rate): Sec. 3, Ch. 41; Sec. 3, Ch. 42
Essential tremor: Sec. 3, Ch. 30
Estrogen
postmenopausal levels of: Sec. 3 Ch. 22 [detail]; Sec. 1, Ch. 2; Sec. 3, Ch. 58
receptors for
     in breast cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51
saw palmetto interaction with: Sec. 2, Ch. 7
synthetic
     in atrophic vaginitis: Sec. 3, Ch. 58
     in osteoporosis: Sec. 3, Ch. 22
     side effects of: Sec. 3, Ch. 22; Sec. 3, Ch. 22
     in stress incontinence: Sec. 3, Ch. 57
     in vaginal bleeding: Sec. 3, Ch. 58
Etanercept: Sec. 3, Ch. 41
Ethacrynic acid: Sec. 3, Ch. 18
dizziness with: Sec. 3, Ch. 20
in heart failure: Sec. 3, Ch. 46
Ethical issues: Sec. 4, Ch. 65
Ethicist: Sec. 2, Ch. 9
Etidronate: Sec. 3, Ch. 22
Eustachian tube: Sec. 3, Ch. 37; Sec. 3, Ch. 37
Euthanasia: Sec. 2, Ch. 16
Event recorder
for abnormal heart rhythms: Sec. 3, Ch. 47
Excessive daytime sleepiness: Sec. 3, Ch. 31; Sec. 3, Ch. 31
Exercise stress testing: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 60
in ventricular tachycardia: Sec. 3, Ch. 47
Exercise
aerobic: Sec. 2, Ch. 13; Sec. 3, Ch. 60
     in arthritis: Sec. 3, Ch. 60
     in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 60
     after stroke: Sec. 3, Ch. 60
abnormal heart rhythms: Sec. 3, Ch. 47
in arthritis: Sec. 3, Ch. 60
in atherosclerosis: Sec. 3, Ch. 44
balance: Sec. 2, Ch. 13; Sec. 3, Ch. 60
benefits of: Sec. 3, Ch. 60
breathing during: Sec. 1, Ch. 2
breathing: Sec. 3, Ch. 52
cardiac function during: Sec. 1, Ch. 1
cooling down from: Sec. 3, Ch. 60
coordination: Sec. 2, Ch. 13
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 60
in dementia: Sec. 3, Ch. 60
in depression: Sec. 3, Ch. 32
in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 60
in disabilities: Sec. 3, Ch. 60
in dystonia: Sec. 3, Ch. 30
for fainting prevention: Sec. 3, Ch. 20
hand: Sec. 3, Ch. 60
health benefits of: Sec. 3, Ch. 60; Sec. 1 Ch. 1 [sidebar]
in heart failure: Sec. 3, Ch. 60
in hot weather: Sec. 3, Ch. 19
intensity of: Sec. 3, Ch. 60
isometric: Sec. 2, Ch. 13; Sec. 3, Ch. 60
     in arthritis: Sec. 3, Ch. 60
isotonic: Sec. 2, Ch. 13; Sec. 3, Ch. 60
Kegel: Sec. 3, Ch. 60
     in incontinence: Sec. 3, Ch. 57
for leg cramps: Sec. 3, Ch. 31
in lung disorders: Sec. 3, Ch. 60
in osteoarthritis: Sec. 3, Ch. 41
pain during: Sec. 3, Ch. 60
in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 60
in peripheral arterial disease: Sec. 3, Ch. 44; Sec. 3, Ch. 60
physician evaluation for: Sec. 3, Ch. 60; Sec. 3, Ch. 60
range-of-motion: Sec. 2, Ch. 13
     after fracture treatment: Sec. 3, Ch. 23
     after stroke: Sec. 2, Ch. 13
in rheumatoid arthritis: Sec. 3, Ch. 41
strengthening: Sec. 1, Ch. 2; Sec. 2, Ch. 13; Sec. 3, Ch. 60
     after fracture treatment: Sec. 3, Ch. 23
stretching: Sec. 3, Ch. 60
in stroke prevention: Sec. 3, Ch. 28
after stroke: Sec. 3, Ch. 60
supervision for: Sec. 3, Ch. 60
in swallowing difficulty: Sec. 3, Ch. 54
vocal: Sec. 3, Ch. 38
in water: Sec. 3, Ch. 41
warming up for: Sec. 3, Ch. 60
in water: Sec. 3, Ch. 60; Sec. 3, Ch. 60; Sec. 3, Ch. 60
Exophthalmos: Sec. 3, Ch. 33
External fixation
for fracture: Sec. 3, Ch. 23; Sec. 3, Ch. 23
Extracorporeal shock wave lithotripsy: Sec. 3, Ch. 41
Eye drops: Sec. 3, Ch. 36
Eye(s)
aging of: Sec. 1, Ch. 2; Sec. 1, Ch. 2
anatomy of: Sec. 3, Ch. 36
blood flow to: Sec. 3, Ch. 36
bulging of (exophthalmos): Sec. 3, Ch. 33
in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 36
disorders of: Sec. 3, Ch. 36
     in progressive supranuclear palsy: Sec. 3, Ch. 30
dry: Sec. 1, Ch. 2; Sec. 3, Ch. 36
emboli of: Sec. 3, Ch. 36
floaters in: Sec. 1, Ch. 2
function of: Sec. 3, Ch. 36
glaucoma of: Sec. 3, Ch. 36
gray-white ring of: Sec. 1, Ch. 2
ischemia of: Sec. 3, Ch. 36
jerking movements of (nystagmus): Sec. 3, Ch. 20
in occipital lobe stroke: Sec. 3, Ch. 36
pressure elevation in (glaucoma)
     dizziness and: Sec. 3, Ch. 20
retina detachment of: Sec. 3, Ch. 36
retinal artery blockage of: Sec. 3, Ch. 36
retinal vein blockage of: Sec. 3, Ch. 36
in shingles: Sec. 3, Ch. 35
sunken appearance of: Sec. 1, Ch. 2
surgery on: Sec. 3 Ch. 36 [sidebar]
tear production in: Sec. 3, Ch. 36
whites of: Sec. 1, Ch. 2
Eyeglasses
dizziness and: Sec. 3, Ch. 20
after cataract surgery: Sec. 3, Ch. 36
Eyelid
chalazion of: Sec. 3, Ch. 36
disorders of: Sec. 3, Ch. 36
inflammation of: Sec. 3, Ch. 36
inward turning of: Sec. 3, Ch. 36
laxity of: Sec. 3, Ch. 36; Sec. 1, Ch. 2
stye of: Sec. 3, Ch. 36
drooping of: Sec. 3, Ch. 36
spasms of: Sec. 3, Ch. 36; Sec. 3, Ch. 30
xanthelasma of: Sec. 3, Ch. 36
Ezetimibe: Sec. 3, Ch. 44
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.